Drug Profile
Metformin controlled release - Andrx Corporation
Alternative Names: ADX 155; Fortamet; Metformin extended-release - Andrx Corporation; Metformin XTLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Andrx Corporation
- Developer Andrx Corporation; Shionogi Pharma
- Class Antihyperglycaemics; Biguanides; Eye disorder therapies; Small molecules
- Mechanism of Action AMP activated protein kinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Type 2 diabetes mellitus